======= GTF2A1 ======= == Gene Information == * **Official Symbol**: GTF2A1 * **Official Name**: general transcription factor IIA subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2957|2957]] * **UniProt**: [[https://www.uniprot.org/uniprot/P52655|P52655]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GTF2A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GTF2A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600520|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: TFIIA is a component of the transcription machinery of RNA polymerase II and plays an important role in transcriptional activation. TFIIA in a complex with TBP mediates transcriptional activity. {ECO:0000269|PubMed:11030333, ECO:0000269|PubMed:16537915}. |TFIIA| |transcription factor TFIIA complex| |RNA polymerase II general transcription initiation factor activity| |TBP-class protein binding| |RNA polymerase II repressing transcription factor binding| |transcription factor TFIID complex| |snRNA transcription by RNA polymerase II| |snRNA transcription| |ncRNA transcription| |transcription initiation from RNA polymerase II promoter| |DNA-templated transcription, initiation| |transcription coactivator activity| |transcription factor binding| |transcription by RNA polymerase II| |protein heterodimerization activity| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |DNA binding| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.73| |[[:results:exp73|LJH685 5μM R02 exp73]]|1.75| |[[:results:exp239|PFI-2 4μM R05 exp239]]|1.79| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.81| |[[:results:exp379|MSC2530818 10μM R07 exp379]]|1.84| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.88| |[[:results:exp180|Dynasore 10μM R04 exp180]]|1.99| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.01| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|2.17| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.18| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|2.46| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 143/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|1/28| |blood|3/28| |bone|3/25| |breast|8/33| |central nervous system|10/56| |cervix|0/4| |colorectal|7/17| |esophagus|0/13| |fibroblast|0/1| |gastric|3/15| |kidney|14/21| |liver|7/20| |lung|9/75| |lymphocyte|3/14| |ovary|12/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|7/15| |prostate|0/1| |skin|2/24| |soft tissue|2/7| |thyroid|1/2| |upper aerodigestive|2/22| |urinary tract|5/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1453 * **Expression level (log2 read counts)**: 5.81 {{:chemogenomics:nalm6 dist.png?nolink |}}